Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas”
1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12428489
Human PD-L2 antibodies and methods of use therefor
granted -
US 12422364
Fluorescence spectral shape analysis for analyte recognition
granted -
US 12420113
Methods and apparatus for applying tumor treating fields combined with personalized ultra-fractionated stereotactic adaptive radiotherapy
granted -
US 12410231
Natural killer cell products and methods
granted -
US 12410232
Treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptor
granted -
US 12410209
Modified glucocorticoids
granted -
US 12404347
Glucuronoxylomannan (GXM) receptor chimeric antigen receptors and use thereof
granted -
US 12403093
Methods for production of MSC-derived exosomes
granted -
US 12396988
Methods of using muscarinic antagonists in the treatment of depression
granted -
US 12390483
Compounds and methods for treating neurological and cardiovascular conditions
granted -
US 12383538
Use of mTOR inhibitors for prevention of intestinal polyp growth and cancer
granted -
US 12378201
Histone demethylase inhibitors for treating cancers
granted -
US 12365761
Biodegradable ultra-pH sensitive polymers
granted -
US 12365664
Small molecule inhibitors of SRC tyrosine kinase
granted -
US 12357659
Production of megakaryocytes or platelets from monocytes
granted -
US 12357580
Lipid nanoparticle compositions for delivery of mRNA and long nucleic acids
granted -
US 12357682
DNA plasmid-launched live-attanuated vaccines for plus-sense singel stranded RNA
granted -
US 12358909
Capsazepine analogs for the treatment of cancer and other proliferative diseases
granted -
US 12359219
Transgene cassettes designed to express a human MECP2 gene
granted -
US 12359204
Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancer
granted -
US 12351560
Next generation FKBP52 targeting drugs for the treatment of prostate and breast cancer
granted -
US 12351609
Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload
granted -
US 12336982
Compositions and methods of modulating short-chain dehydrogenase activity
granted -
US 12336976
Glutaminase inhibitor therapy
granted